Skip to NavigationSkip to content

News

Merck Sharpe & Dohme Cozaar has gained a new UK licence for renal protection in patients with type II diabetes and nephropathy.
Eli Lilly is to embark on an ambitious product launch schedule over the next two years to overcome the patent loss of its biggest earning product,...
UK vaccines manufacturer PowderJect has seen its profits rise on the back of strong sales of its flu vaccine Fluvirin.
The Chief Executive of Bayer has conceded the company cannot continue alone, and has now declared the company open to takeover offers from...
The Chairman of British Biotech has reiterated the company aim to pursue an acquisition or merger following the departure of Chief Executive Dr...
Alzheimer patients in a quarter of all health authorities are still not receiving the latest medicines despite NICE guidance being in place for...
New networks of excellence in pharmaceutical research must be established if Europe is to catch up with world leading US R&D communities,...
AstraZeneca has been boosted by the first regulatory approval in the Netherlands of Crestor, its uperstatincholesterol treatment.
Doctors' leaders have rejected Heath Secretary Alan Milburn latest idea to break the deadlock over the new consultant contract.
GlaxoSmithKline Consumer Healthcare is to expand its use of In2Focus sales representatives to promote its smoking cessation product NiQuitin CQ in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches